New CIHI report says Rx medicines not a burden to the Canadian health care system

3 November 2010

The latest figures from the Canadian Institute for Health Information (CIHI) on health expenditure estimates in Canada show medicines are no longer the fastest growing component in the country’s health care system. The numbers indicate the drug budget in Canada grew by only 4.8% from 2009, compared to a 6.3% increase in 2008. According to the CIHI, the 2010 rate of growth for drugs is expected to be smaller than hospitals and doctors.

Total spending on health care in Canada is expected to reach C$191.6 billion ($188.29 billion) this year, growing an estimated $9.5 billion, or 5.2%, since 2009, according to new figures released by the CIHI This represents an increase of C$216 per Canadian, bringing total health expenditure per capita to an estimated $5,614. After removing the effects of inflation and population growth, health care spending per person is expected to increase by 1.4% in 2010, the lowest annual growth rate seen in 13 years.

C$31.1 billion 2010 drug spending

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical